Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

705 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Adherence to therapy in people with rheumatic and musculoskeletal diseases in Italy and the role of the digital health: results of an expert Delphi consensus survey.
Iagnocco A, Ciccia F, Conti F, D'Angelo S, Epis OM, Govoni M, Guiducci S, Iannone F, Mosca M, Salaffi F, Sebastiani GD, Sonnati M, Caporali RF. Iagnocco A, et al. Among authors: mosca m. Clin Exp Rheumatol. 2023 Sep;41(9):1917-1925. doi: 10.55563/clinexprheumatol/uip1u1. Epub 2023 Jun 28. Clin Exp Rheumatol. 2023. PMID: 37382465 Review.
Assessing disease activity of rheumatoid arthritis patients and drug-utilization patterns of biologic disease-modifying antirheumatic drugs in the Tuscany region, Italy.
Convertino I, Cazzato M, Tillati S, Giometto S, Gini R, Valdiserra G, Cappello E, Ferraro S, Bonaso M, Bartolini C, Paoletti O, Lorenzoni V, Trieste L, Filippi M, Turchetti G, Cristofano M, Blandizzi C, Mosca M, Lucenteforte E, Tuccori M. Convertino I, et al. Among authors: mosca m. Front Pharmacol. 2023 Sep 25;14:1244486. doi: 10.3389/fphar.2023.1244486. eCollection 2023. Front Pharmacol. 2023. PMID: 37818193 Free PMC article.
ToRaRI (Tofacitinib in Rheumatoid Arthritis a Real-Life experience in Italy): Effectiveness, safety profile of tofacitinib and concordance between patient-reported outcomes and physician's global assessment of disease activity in a retrospective study in Central-Italy.
D'Alessandro F, Cazzato M, Laurino E, Morganti R, Bardelli M, Frediani B, Buongarzone C, Moroncini G, Guiducci S, Cometi L, Benucci M, Ligobbi F, Marotto D, Mosca M. D'Alessandro F, et al. Among authors: mosca m. Clin Rheumatol. 2024 Feb;43(2):657-665. doi: 10.1007/s10067-023-06836-w. Epub 2023 Dec 23. Clin Rheumatol. 2024. PMID: 38135860 Free PMC article.
COVID-19 prognosis in systemic lupus erythematosus compared with rheumatoid arthritis and spondyloarthritis: results from the CONTROL-19 Study by the Italian Society for Rheumatology.
Scirocco C, Ferrigno S, Andreoli L, Fredi M, Lomater C, Moroni L, Mosca M, Raffeiner B, Carrara G, Landolfi G, Rozza D, Zanetti A, Scirè CA, Sebastiani GD. Scirocco C, et al. Among authors: mosca m. Lupus Sci Med. 2023 Oct;10(2):e000945. doi: 10.1136/lupus-2023-000945. Lupus Sci Med. 2023. PMID: 37848262 Free PMC article.
Philadelphia chromosome-negative myeloproliferative chronic neoplasms: is clonal hematopoiesis the main determinant of autoimmune and cardio-vascular manifestations?
Fulvio G, Baldini C, Mosca M, di Paolo A, Bocci G, Palumbo GA, Cacciola E, Migliorini P, Cacciola R, Galimberti S. Fulvio G, et al. Among authors: mosca m. Front Med (Lausanne). 2023 Oct 17;10:1254868. doi: 10.3389/fmed.2023.1254868. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37915324 Free PMC article. Review.
Real life data on nintedanib safety: idiopathic pulmonary fibrosis versus systemic sclerosis-interstitial lung disease and strategies adopted to manage adverse effects.
Di Battista M, Tavanti L, Pistelli F, Carrozzi L, Da Rio M, Rossi A, Puccetti L, Tavoni A, Romei C, Morganti R, Della Rossa A, Mosca M. Di Battista M, et al. Among authors: mosca m. Inflammopharmacology. 2023 Oct;31(5):2445-2449. doi: 10.1007/s10787-023-01286-x. Epub 2023 Aug 3. Inflammopharmacology. 2023. PMID: 37535212 Free PMC article.
Challenges and opportunities in transitional care process in Behçet's syndrome.
Di Cianni F, Mastrolia MV, Biancalana E, Marinello D, Emmi G, Mosca M, Simonini G, Talarico R. Di Cianni F, et al. Among authors: mosca m. Front Med (Lausanne). 2024 Sep 18;11:1456063. doi: 10.3389/fmed.2024.1456063. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39359917 Free PMC article.
705 results